Biovica acquires cSens AB - creating opportunities for solving cancer diagnostic chal

[News]

Biovica has acquired cSens AB, a company that has developed a PCR-based platform for the analysis of serum thymidine kinase (TK) enzyme activity, which correspond to tumor proliferation and cancer aggressiveness.

More... (http://www.news-medical.net/news/20160518/Biovica-acquires-cSens-AB-creating-opportunities-for-solving-cancer-diagnostic-challenges.aspx)